Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-09-025709
Filing Date
2009-12-18
Accepted
2009-12-18 16:46:33
Documents
1
Period of Report
2009-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7440
  Complete submission text file 0001127602-09-025709.txt   9294
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747
Business Address
Rachman Jonathan (Reporting) CIK: 0001471222 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 091250585